Previously, inhibition of the ATR-CHK1 DDR pathway in expressed pancreatic ductal adenocarcinoma (PDAC) cells resulted in ERK activation, which is a key downstream protein of KRAS [70]. The gene discussed is ATR; the disease is pancreatic ductal adenocarcinoma.